<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="Publisher" Owner="NLM">        <PMID Version="1">30333222</PMID>        <DateRevised>            <Year>2018</Year>            <Month>10</Month>            <Day>26</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1538-7755</ISSN>                <JournalIssue CitedMedium="Internet">                    <PubDate>                        <Year>2018</Year>                        <Month>Oct</Month>                        <Day>17</Day>                    </PubDate>                </JournalIssue>                <Title>Cancer epidemiology, biomarkers &amp; prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology</Title>                <ISOAbbreviation>Cancer Epidemiol. Biomarkers Prev.</ISOAbbreviation>            </Journal>            <ArticleTitle>Breast Cancer Mortality in Older and Younger Breast Cancer Patients in California.</ArticleTitle>            <ELocationID EIdType="pii" ValidYN="Y">cebp.0353.2018</ELocationID>            <ELocationID EIdType="doi" ValidYN="Y">10.1158/1055-9965.EPI-18-0353</ELocationID>            <Abstract>                <AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Breast cancer in younger patients is reported to be more aggressive and associated with lower survival; however, factors associated with age-specific mortality differences have not been adequately assessed.</AbstractText>                <AbstractText Label="METHODS" NlmCategory="METHODS">We used data from the population-based California Cancer Registry for 38,509 younger (18-49 years) and 121,573 older (50 years and older) women diagnosed with Stage I-III breast cancer, 2005-2014. Multivariable Cox regression models were used to estimate breast cancer specific mortality rate ratios (MRR) and 95% confidence intervals (CI), stratified by tumor subtype, guideline treatment, and care at a National Cancer Institute-designated cancer center (NCICC).</AbstractText>                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Older breast cancer patients at diagnosis experienced 17% higher disease-specific mortality than younger patients, after multivariable adjustment (MRR=1.17; 95% CI, 1.11-1.23). Higher MRRs (95% CI) were observed for older versus younger patients with hormone receptor (HR)+/HER2- [1.24 (1.14-1.35)] and HR+/HER2+ [1.38 (1.17-1.62)], but not for HR-/HER2+ [HR=0.94; 0.79-1.12)] nor triple-negative breast cancers [1.01; 0.92-1.11)]. The higher mortality in older versus younger patients was diminished among patients who received guideline-concordant treatment (MRR=1.06; 95% CI, 0.99-1.14) and reversed among those seen at an NCICC (MRR=0.86; 95% CI, 0.73-1.01).</AbstractText>                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">While younger women tend to be diagnosed with more aggressive breast cancers, adjusting for these aggressive features results in older patients having higher mortality than younger patients, with variations by age, tumor subtype, receipt of guideline treatment, and being cared for at a NCICC.</AbstractText>                <AbstractText Label="IMPACT" NlmCategory="CONCLUSIONS">Higher breast cancer mortality in older compared to younger women could partly be addressed by ensuring optimal treatment and comprehensive patient-centered care.</AbstractText>                <CopyrightInformation>Copyright Â©2018, American Association for Cancer Research.</CopyrightInformation>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Tao</LastName>                    <ForeName>Li</ForeName>                    <Initials>L</Initials>                    <AffiliationInfo>                        <Affiliation>Greater Bay Area Cancer Registry, Cancer Prevention Institute of California.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Schwab</LastName>                    <ForeName>Richard B</ForeName>                    <Initials>RB</Initials>                    <AffiliationInfo>                        <Affiliation>Center for Personalized Cancer Therapy, and Division of Hematology and Oncology, UCSD Moores Cancer Center.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>San Miguel</LastName>                    <ForeName>Yazmin</ForeName>                    <Initials>Y</Initials>                    <Identifier Source="ORCID">https://orcid.org/0000-0002-3682-228X</Identifier>                    <AffiliationInfo>                        <Affiliation>Moores Cancer Center, University of California, San Diego.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Gomez</LastName>                    <ForeName>Scarlett Lin</ForeName>                    <Initials>SL</Initials>                    <AffiliationInfo>                        <Affiliation>Epidemiology and Biostatistics, University of California, San Francisco.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Canchola</LastName>                    <ForeName>Alison J</ForeName>                    <Initials>AJ</Initials>                    <AffiliationInfo>                        <Affiliation>Cancer Prevention Institute of California.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Gago-Dominguez</LastName>                    <ForeName>Manuela</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>University of California San Diego Moores Cancer Center, Fundacion Gallega Medicina Genomica, IDIS Santiago de C. Spain.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Komenaka</LastName>                    <ForeName>Ian K</ForeName>                    <Initials>IK</Initials>                    <AffiliationInfo>                        <Affiliation>Surgery, Maricopa Medical Center.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Murphy</LastName>                    <ForeName>James D</ForeName>                    <Initials>JD</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Radiation Medicine and Applied Sciences, Radiation Oncology PET/CT Center, University of California San Diego, Moores Cancer Center.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Molinolo</LastName>                    <ForeName>Alfredo A</ForeName>                    <Initials>AA</Initials>                    <Identifier Source="ORCID">https://orcid.org/0000-0001-8412-2889</Identifier>                    <AffiliationInfo>                        <Affiliation>Dept of Pathology, University of California San Diego, Moores Cancer Center.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Martinez</LastName>                    <ForeName>Maria Elena</ForeName>                    <Initials>ME</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Family Medicine and Public Health, University of California, San Diego e8martinez@ucsd.edu.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <GrantList CompleteYN="Y">                <Grant>                    <GrantID>P30 CA023100</GrantID>                    <Acronym>CA</Acronym>                    <Agency>NCI NIH HHS</Agency>                    <Country>United States</Country>                </Grant>                <Grant>                    <GrantID>U54 CA132379</GrantID>                    <Acronym>CA</Acronym>                    <Agency>NCI NIH HHS</Agency>                    <Country>United States</Country>                </Grant>                <Grant>                    <GrantID>U54 CA132384</GrantID>                    <Acronym>CA</Acronym>                    <Agency>NCI NIH HHS</Agency>                    <Country>United States</Country>                </Grant>            </GrantList>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>10</Month>                <Day>17</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>United States</Country>            <MedlineTA>Cancer Epidemiol Biomarkers Prev</MedlineTA>            <NlmUniqueID>9200608</NlmUniqueID>            <ISSNLinking>1055-9965</ISSNLinking>        </MedlineJournalInfo>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>10</Month>                <Day>10</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>04</Month>                <Day>04</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="revised">                <Year>2018</Year>                <Month>08</Month>                <Day>08</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>10</Month>                <Day>19</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>10</Month>                <Day>20</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>10</Month>                <Day>20</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>aheadofprint</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30333222</ArticleId>            <ArticleId IdType="pii">1055-9965.EPI-18-0353</ArticleId>            <ArticleId IdType="doi">10.1158/1055-9965.EPI-18-0353</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>